IL-6 might relieve long-standing thrombocytopenia in autotransplanted AML patients

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Leukemia·2013

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

British journal of cancer·2012

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Leukemia·2011

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Leukemia·2003

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.

European journal of haematology·2003

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.

British journal of cancer·2002

Optimizing cord blood unit selection to improve survival after single-unit unrelated cord blood transplantation for adult myelodysplastic syndrome.

British journal of haematology·2026

A pro-inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation.

British journal of haematology·2026

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera.

British journal of haematology·2026

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

British journal of haematology·2026

Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.

British journal of haematology·2026

Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft-versus-host disease.

British journal of haematology·2026

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Cancer management and research·2026

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

HemaSphere·2026

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

F1000Research·2026

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Journal of translational medicine·2026

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Blood reviews·2026

Related Experiment Videos

IL-6 might relieve long-standing thrombocytopenia in autotransplanted AML patients

Related Concept Videos

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

Somatic MED12 mutations in uterine leiomyosarcoma and colorectal cancer.

Development of standardized approaches to reporting of minimal residual disease data using a reporting software package designed within the European LeukemiaNet.

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Validation and clinical implication of a quantitative real-time PCR determination of MDR1 gene expression: comparison with semi-quantitative PCR in 101 patients with acute myeloid leukemia.

Presence of clone-specific markers at birth in children with acute lymphoblastic leukaemia.

Optimizing cord blood unit selection to improve survival after single-unit unrelated cord blood transplantation for adult myelodysplastic syndrome.

A pro-inflammatory cytokine signature characterises thrombotic antiphospholipid syndrome despite stable anticoagulation.

Estimated pulse wave velocity as a marker of major adverse cardiovascular events in essential thrombocythaemia and polycythaemia vera.

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

Predicted microbiome-associated metabolic pathways are linked to immune checkpoint modulation in chronic lymphocytic leukaemia.

Serum thioredoxin at allogeneic haematopoietic stem cell transplantation predicts acute graft-versus-host disease.

Severe Immune-Related Adverse Events Associated with Durable Antitumor Responses Following Immune Checkpoint Inhibitor Therapy: Two Case Reports.

Clonotypic characterization defines B-cell drivers of clonal expansion and intratumor heterogeneity in IgM monoclonal gammopathies.

A guide to selecting high-performing antibodies for Syntenin-1 (O00560) for use in western blot, immunoprecipitation, and immunofluorescence.

A guide to selecting high-performing renewable antibodies for KIF5A (Q12840) across western blot, immunoprecipitation, and immunofluorescence.

SARS-CoV-2-specific T cells cross-react with tumor-associated antigens via molecular mimicry.

Beyond the platelet count: A systematic review of artificial intelligence in immune thrombocytopenia.

Related Experiment Videos

IL-6 might relieve long-standing thrombocytopenia in autotransplanted AML patients

Related Concept Videos

Related Articles